This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hypothalamus-pituitary-gonad axis (in menstrual cycle)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In the fifth month of intrauterine life the primordial follicles in the female fetus reach their maximum number (about 6 to 7 million per ovary). From this point in development follicles grow and become atretic - a process that is independent of stimulation by gonadotrophins and occurs during all physiological circumstances including ovulation, pregnancy and periods of anovulation. After initiation of follicular growth then the follicle progresses to the preantral stage of development (enlarged oocyte surrounded by zona pellucida).

Further development of the follicle is dependent on the onset of puberty. Puberty results in changes in sensitivity in the hypothalamus-pituitary-gonad axis that result in pulsed release of gonadotrophin releasing hormone. This in turn results in release of luteninizing hormone (LH) and follicle stimulating hormone (FSH) by the anterior pituitary. After puberty there is pulsed release of FSH and LH every 70-220 minutes dependent on the particular phase of the menstrual cycle. The control of the release of FSH and LH is modulated by the feedback of steroids (on the hypothalamus and pituitary).

The hormonal changes that occur during the menstrual cycle can be divided into:

  • follicular phase
  • ovulation
  • luteal phase

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.